Spyre Therapeutics
SYRE
SYRE
28 hedge funds and large institutions have $38M invested in Spyre Therapeutics in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.37M | |
| 2 | +$236K | |
| 3 | +$123K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94K |
| 5 |
SCM
Sio Capital Management
New York
|
+$79.8K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$171K | |
| 3 | -$149K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$62K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$41.6K |